This study also found that several factors of PRP are also associated with clinical outcomes and correlate with clinical symptoms, such as IL-4 level for patients with IC/BPS, and TGF-β2 for patients with rUTI. The gene discussed is TGFB2; the disease is Bartsocas-Papas syndrome 1.